ldn and semaglutide Living Your Healthiest Life: A… by Summer Kessel · Audiobook preview Comparing Semaglutide, Liraglutide, and Tirzepatide:
Description
Silver Spring, MD Joined January 2022
Her clinical interests include endothelial dysfunction and vulnerable plaque
PMID: 39366501 Int Immunopharmacol Exendin-4 intervention attenuates atherosclerosis severity by modulating myeloid-derived suppressor cells and inflammatory cytokines in ApoE-/- mice
doi:10.1016/j.cjca.2014.11.031 Katsiki N, Mikhailidis DP, Banach M
The REWIND trial (dulaglutide) found acute pancreatitis in 0.5% of dulaglutide patients versus 0.4% of placebo patients
research grants from AstraZeneca and PlaqueTec
